Literature DB >> 10091174

Final height and endocrine function in thalassaemia intermedia.

V De Sanctis1, A Tangerini, M R Testa, A L Lauriola, M R Gamberini, A R Cavallini, F Rigolin.   

Abstract

We present data of a detailed study of endocrine function in 50 patients (21 males, 29 females) with thalassaemia intermedia, 15-46 years old (mean age 28.7 yr), with raised serum ferritin levels (mean 1540 micrograms/l). Mean haemoglobin concentration was 8.1 g/dl. Half of them had had more than 50 transfusions in their life and had received irregular intramuscular or subcutaneous chelation therapy. Delayed puberty was one of the most frequent (36%) clinical endocrine abnormalities found in our patients. Primary amenorrhea was observed in two patients and secondary amenorrhea in four patients. Two males, aged 19 and 36 years, had hypogonadism. A poor response to GnRH, found in three females and in both males tested, suggested that pituitary dysfunction was wholly or partially responsible for hypogonadism. Gonadal function was normal in all patients studied. Glucose intolerance and primary hypothyroidism were less frequent (24 and 5.7%, respectively) and milder than in thalassaemia major patients. Two patients had low T3 and T4 and normal basal and stimulated response of TSH to TRH. This condition has been found in euthyroid sick syndrome and it is likely that it represents an adaptive response by the body to minimize catabolism when undergoing major stress. As a consequence, we believe that periodic endocrine evaluation should be carried out in subjects with beta-thalassaemia intermedia, particularly in those over 14 years old, in order to detect and to treat endocrine dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10091174

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

Review 1.  Beta-thalassemia.

Authors:  Renzo Galanello; Raffaella Origa
Journal:  Orphanet J Rare Dis       Date:  2010-05-21       Impact factor: 4.123

Review 2.  Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.

Authors:  Adlette Inati; MohammadHassan A Noureldine; Anthony Mansour; Hussein A Abbas
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

Review 3.  Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis study.

Authors:  Milad Azami; Ali Sharifi; Siros Norozi; Akram Mansouri; Kourosh Sayehmiri
Journal:  Caspian J Intern Med       Date:  2017

4.  Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.

Authors:  Mohamed A Yassin; Ashraf T Soliman; Vincenzo De Sanctis; Khadra S Yassin; Mohammad Aj Abdulla
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-05-01       Impact factor: 2.576

5.  The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study.

Authors:  Antonella Meloni; Laura Pistoia; Maria Rita Gamberini; Paolo Ricchi; Valerio Cecinati; Francesco Sorrentino; Liana Cuccia; Massimo Allò; Riccardo Righi; Priscilla Fina; Ada Riva; Stefania Renne; Giuseppe Peritore; Stefano Dalmiani; Vincenzo Positano; Emilio Quaia; Filippo Cademartiri; Alessia Pepe
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

6.  Endocrine function in thalassemia intermedia.

Authors:  H Karamifar; M Karimi; G H Amirhakimi; M Badiei
Journal:  Int J Biomed Sci       Date:  2006-09

Review 7.  Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis.

Authors:  Gholamreza Badfar; Akram Mansouri; Masoumeh Shohani; Hamid Karimi; Zahra Khalighi; Shoboo Rahmati; Ali Delpisheh; Yousef Veisani; Ali Soleymani; Milad Azami
Journal:  Caspian J Intern Med       Date:  2017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.